I. RESTATEMENT (Details 1) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Research and development expenses	$ 3,548,257	$ 4,692,908
Total operating expenses	4,955,266	5,327,509
Operating loss	(4,938,008)	(5,306,533)
Interest income (expense), net	(469,151)	(483,693)
Net income	$ 3,521,153	$ 2,332,734
Net income per share - basic	$ 0.59	$ 0.53
Net income per share - diluted	$ 0.32	0.53
Net income per share - basic and diluted		$ 0.53
Previously Reported
Research and development expenses	$ 4,024,856	$ 5,169,507
Total operating expenses	5,431,865	5,804,108
Operating loss	(5,414,607)	(5,783,132)
Interest income (expense), net	23,097	1,985
Net income	$ 3,536,802	$ 2,341,813
Net income per share - basic	$ 0.59
Net income per share - diluted	$ 0.33
Net income per share - basic and diluted		$ 0.53
Adjustment
Research and development expenses	$ (476,599)	$ (476,599)
Total operating expenses	(476,599)	(476,599)
Operating loss	476,599	476,599
Interest income (expense), net	(492,248)	(485,678)
Net income	$ (15,649)	$ (9,079)